Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Off-the-shelf therapies to be developed for entire groups of patients
Prof. Yardena Samuels is the recipient of the Michael Bruno Memorial Award from the Israel Institute for Advanced Studies at the Hebrew University...
The findings of a new study may explain the microbiome-immunotherapy connection
A study of melanoma cells explains a puzzling response they exhibit to ward off T cell attacks
Prof. Yardena Samuels is the recipient of the 2020 Estela Medrano Award
Prof. Yardena Samuels has been elected as a member of EMBO
Overexpression of certain immunoproteasome subunits in melanoma are tied to anti-cancer immune activity
Prof. Yardena Samuels has been elected as a Member of the European Academy of Cancer Sciences.
Weizmann Institute of Science research shows heterogeneity in melanoma tumors prevents effective immune responses
...
A new approach to identifying “signposts” on cancer cells may help immune cells eliminate the disease